Meisoindigo 50mg | ≥99%
CSNpharm
Meisoindigo, a derivative of Indigo naturalis with anticancer activity, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).
More Information Supplier PageMeisoindigo
Search Results
Meisoindigo 5mg | ≥99%
CSNpharm
Meisoindigo, a derivative of Indigo naturalis with anticancer activity, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).
More Information Supplier PageMeisoindigo
Mepenzolate Bromide 1g | ≥98%
CSNpharm
Mepenzolate bromide mAchR antagonist, working as a post-ganglionic parasympathetic inhibitor to decrease gastric acid and pepsin secretion and suppresse spontaneous contractions of the colon.
More Information Supplier PageMepenzolate Bromide
Mafenide Acetate 100mg | ≥98%
CSNpharm
Mafenide Acetate is a synthetic sulfonamide-derived with topical anti-infective activity, which acts through competition with PABA for the bacterial enzyme dihydropteroate synthase and thereby interfering with normal folic acid metabolism.
More Information Supplier PageMafenide Acetate
Mafenide Acetate 1g | ≥98%
CSNpharm
Mafenide Acetate is a synthetic sulfonamide-derived with topical anti-infective activity, which acts through competition with PABA for the bacterial enzyme dihydropteroate synthase and thereby interfering with normal folic acid metabolism.
More Information Supplier PageMafenide Acetate
Mafenide Acetate 50mg | ≥98%
CSNpharm
Mafenide Acetate is a synthetic sulfonamide-derived with topical anti-infective activity, which acts through competition with PABA for the bacterial enzyme dihydropteroate synthase and thereby interfering with normal folic acid metabolism.
More Information Supplier PageMafenide Acetate
Mafenide Acetate 250mg | ≥98%
CSNpharm
Mafenide Acetate is a synthetic sulfonamide-derived with topical anti-infective activity, which acts through competition with PABA for the bacterial enzyme dihydropteroate synthase and thereby interfering with normal folic acid metabolism.
More Information Supplier PageMafenide Acetate
LY294002 10mg | ≥99%
CSNpharm
LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays.
More Information Supplier PageLY294002
LY294002 100mg | ≥99%
CSNpharm
LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays.
More Information Supplier PageLY294002
LY294002 50mg | ≥99%
CSNpharm
LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays.
More Information Supplier PageLY294002